Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
INSIGHT PROVIDER
Top 5%
Xinyao (Criss) Wang
HK/China Healthcare Analyst (ex-Fosun Pharma)
Message
Follow
Location:
China
Joined:
02 October 2020
1.0k
Insights
364.5k
Views
452
Followers
China
•
Health Care
•
Equity Bottom-Up
•
Thematic (Sector/Industry)
Message
Follow
Regions
Sectors
Verticals
More Filters
Refresh
Top Picks Only
Recent
bullish
•
CPMC Holdings
•
25 Jul 2024 08:55
CPMC Holdings (906.HK) Privatization Update - The Story Behind the Delay of Offer Document Despatch
Baosteel makes solid progress in acquiring CPMC, and this type of merger is in line with the idea of integration of SOEs. Comparatively, ORG may...
Xinyao (Criss) Wang
259 Views
Share
bearish
•
TYK Medicines
•
24 Jul 2024 08:55
Pre-IPO TYK Medicines (PHIP Updates) - Some Points Worth the Attention
TYK has differentiated indication for core product, but it faces uncertainty in R&D. Cash shortage is an issue. We recommend a more cautious...
Xinyao (Criss) Wang
255 Views
Share
bullish
•
L'Occitane
•
24 Jul 2024 08:49
L'Occitane (973.HK) - The Privatization Is About to Succeed
The Offeror has received valid acceptances that would result in Offeror holding no less than 90% of the Disinterested Shares (91.97% of Total...
Xinyao (Criss) Wang
885 Views
Share
bearish
•
Saint Bella
•
23 Jul 2024 08:55
Pre-IPO Saint Bella - The Outlook for Future Performance Growth Is Highly Uncertain
Increasing contract liabilities ensure SAINT BELLA's short-term performance but declining fertility rate in China pose long-term challenge.We're...
Xinyao (Criss) Wang
265 Views
Share
bearish
•
Elpiscience Biopharmaceuticals
•
22 Jul 2024 08:55
Pre-IPO Elpiscience Biopharmaceuticals - Will Investors Still Buy in These Stories?
Elpiscience's strong capital operation capabilities are no longer enough as investors shift focus to cash flow and drug sales revenue. We have...
Xinyao (Criss) Wang
208 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.9
x